The Western blot results indicated that LHX2 activated the PI3K/AKT/mTOR pathway and apoptosis pathway in breast cancer, and it inhibited the apoptosis of BRCA (Figure 9A–D). This evidence concerns the gene LHX2 and breast carcinoma.